Safety and efficacy depend on the compounding pharmacy you buy from and the formulation used
The long-acting GLP-1 agonist segment dominated the market in 2025 owing to its superior dosing convenience, improved patient observation, and sustained therapeutic efficacy
This personalised approach to titration is an important safety feature and underscores why retatrutide must only be used under close medical supervision within an approved research framework
Why Caffeine Feels Different on GLP-1 Therapy Women often report that caffeine feels stronger after starting GLP-1 therapy
Those with a history of telogen effluvium, thyroid disorders, or low iron levels may also be at higher risk
Patients on these combinations require proactive clinician-directed dose adjustments of concomitant medications, particularly insulin, to prevent hypoglycemic episodes